Studies of the mammalian cell cycle in vivo have been hampered by the lack of pure populations of proliferating cells. In this issue of Developmental Cell, Klochendler and colleagues (2012) develop a novel transgenic mouse that expresses Cyclin B1-GFP ubiquitously. By sorting and analyzing proliferating hepatocytes, they provide evidence for their transient dedifferentiation.
For a long time, an important question for cell biologists has been whether, or to what degree, eukaryotic cells dedifferentiate during cellular replication. While much information about cell-cycle control has been gained from the study of immortalized cell lines, these cells do not fully represent terminally differentiated cells that exist in tissues and are thus not a good model to address this question. Analyzing cycling cells in vivo has proven to be difficult in the past for several reasons. First, in continuously regenerating tissues such as skin and intestine, rapidly cycling stem and progenitor cells maintain tissue homeostasis but differentiate only after exit from the cell cycle. Second, even in tissues such as the liver, in which massive, near-synchronous reentry into the cell cycle of mature hepatocytes can be triggered by surgical removal of two-thirds of the organ, less than half of hepatocytes enter the cell cycle; thus, any biochemical and molecular analysis of proliferating cells is hampered by contamination of noncycling cells.
In principle, this problem could be approached through the use of thymidine analogs that are incorporated into cellular DNA during replication, or S phase. Indeed, these reagents have been used successfully for decades for post hoc analysis of proliferating cells in vivo and have been very useful, for instance, in the evaluation of the efficacy of various mitogens and the analysis of animals with mutations in cell-cycle regulators. However, these reagents require the fixation of the tissue on subsequent immunological detection of the incorporated label. Thus, the isolation and molecular analysis of live proliferating cells from mammalian tissues has proven to be challenging.
The study by Klochendler and colleagues (2012) in the current issue of Developmental Cell provides an elegant solution to the problem. The authors reasoned that a fluorescent protein fused to the so-called ''destruction box'' of Cyclin B1 could be employed to mark and sort cycling cells in vivo. This idea is based on the discovery more than 10 years ago that the protein levels of Cyclin B1 are controlled by ubiquitin-mediated degradation, beginning in M phase of the cell cycle (Sudakin et al., 1995) . Specifically, Klochendler and colleagues employed a fusion protein of the first 105 amino acids of Cyclin B1, containing the RXXL destruction box, with the jellyfish green fluorescent protein (GFP), because this chimeric molecule had been shown to mimic the cell-cycle behavior of endogenous Cyclin B1 in cultured cells (Zur and Brandeis, 2002) . Because Cyclin B1-GFP, just like endogenous Cyclin B1, is synthesized de novo in S phase, in these transgenic mice GFP is present in cycling cells through S, G2, and M phases of the cell cycle.
After careful validation of their new transgenic model, Klochendler and colleagues demonstrate its usefulness by analyzing the gene expression profile of cycling hepatocytes (Klochendler et al., 2012) . Because replication of hepatocytes in the uninjured liver of the adult mammals is negligible, they used growing livers of juvenile animals in which about 10% of hepatocytes are cycling. As expected, GFP-positive and thus cycling hepatocytes expressed many established proliferation markers-such as Ki67 and Cyclin B1 itself-at high levels, demonstrating the validity of the new model. Of particular interest is their finding that a large set of ''differentiation-associated'' genes had reduced expression in cycling hepatocytes. Among these are the genes encoding enzymes involved in glycolysis, lipid, and xenobiotic metabolism. This observation confirms and extends a prior gene expression profiling study in which whole liver was analyzed at various time points following partial hepatectomy (White et al., 2005) . It is clear, then, that replicating hepatocytes undergo partial transcriptional dedifferentiation.
A long-standing question has been to what degree the dedifferentiation that occurs in hepatocellular carcinoma is tumor specific. Klochendler and colleagues suggest that this, in fact, is a property of all cycling hepatocytes, whether cancerous or not. In contrast, the gene expression signature characteristic of fetal cells, such as expression of the heptoblast marker alpha-feto protein, was not seen in replicating normal hepatocytes, whereas it is a common feature in liver cancer. Thus, their comprehensive profiling of dividing normal hepatocytes has already identified important similarities and differences to hepatocellular carcinoma. The transgenic mouse model described above is of course useful not only for the study of proliferation in the liver, but also of all cell types, because the authors employed a ubiquitous promoter to drive expression of the Cyclin B1-GFP fusion protein. Thus, the application of sorting of live, proliferating cells can now be expanded to the rare replicating neuron, just as it can be to the rapidly regenerating intestinal epithelium. Future work could also make use of intercrossing of the current transgenic line with other transgenic mice expressing fluorescent proteins with different excitation/emission properties in cells of interest, thus allowing for dual-label sorting of replicating cells from complex tissues. The novel tool developed by Klochendler and colleagues thus represents in a major step forward in the analysis of proliferation of normal mammalian cells and tissues.
